Karlov V A, Belotskiĭ S M, Filiukova O B, Zueva V S, Solov'ev V D
Antibiot Med Biotekhnol. 1985 Oct;30(10):770-3.
Administration of leukocytic interferon to patients with sepsis and purulent resorptive fever resulted in a reliable increase in the indices of the host protective factors with respect to the infections. Addition of interferon to the surgical and antibacterial treatment promoted a decrease in the periods providing the clinical effect to 19.8 days against 43.8 days in the treatment without interferon.
对脓毒症和脓性吸收热患者给予白细胞干扰素,可使宿主针对感染的保护因子指标可靠增加。在外科手术和抗菌治疗中添加干扰素,可使产生临床效果的时间缩短至19.8天,而未使用干扰素的治疗时间为43.8天。